Summary:
Promoting Integrity in Medicare Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to the general exceptions to both ownership and compensation arrangement prohibitions against physician self-referrals of Medicare patients to the entity with which a physician has a certain financial relationship.

Removes from the in-office ancillary services (IOAS) exception to such prohibitions certain services the Secretary of Health and Human Services (HHS) determines are not usually provided and completed during the visit to a physician's office in which such a service is determined to be necessary (non-ancillary services). (Thus subjects such non-ancillary services to the prohibitions against physician self-referrals).

Lists among specified non-ancillary services: (1) anatomic pathology services (including the technical or professional component of surgical pathology, cytopathology, hematology, blood banking, and pathology consultation and clinical laboratory interpretation services), (2) radiation therapy services and supplies, (3) advanced diagnostic imaging studies, and (4) physical therapy services.

Increases from a maximum of $15,000 to a maximum of $25,000 the civil monetary penalty in the case of a bill or claim for such services whose presenter knows or should have known they are for a service for which payment may not be made.

Increases from a maximum of $100,000 to a maximum of $150,000 the civil monetary penalty for any circumventive arrangement or scheme which a physician or other entity enters into knowing (or should know) has a principal purpose of assuring referrals by the physician to a particular entity which, if the physician directly made referrals to such entity, would be in violation of SSA title XVIII.

Directs the Secretary to review compliance with the self-referral prohibitions with respect to referrals for specified non-ancillary services in accordance with procedures established by the Secretary.

States that, in applying the self-referral prohibitions, the term "entity" includes a physician's practice when it bills under Medicare for the technical component or the professional component of a specified non-ancillary service.

promoting integrity medicare_act amends title xviii medicare social_security_act ssa respect general exceptions ownership compensation arrangement prohibitions physician self referrals medicare patients entity physician certain financial relationship removes office ancillary services exception prohibitions certain services secretary health_and_human_services hhs determines usually provided completed visit physician office service determined necessary non ancillary services subjects non ancillary services prohibitions physician self referrals lists specified non ancillary services pathology services including technical professional component surgical pathology blood banking pathology consultation clinical laboratory interpretation services radiation therapy services supplies advanced diagnostic imaging studies physical therapy services increases maximum maximum civil monetary penalty case bill claim services knows known service payment increases maximum maximum civil monetary penalty arrangement scheme physician entity enters knowing know principal purpose assuring referrals physician particular entity physician directly referrals entity violation ssa title xviii directs secretary review compliance self referral prohibitions respect referrals specified non ancillary services accordance procedures established secretary states applying self referral prohibitions term entity includes physician practice bills medicare technical component professional component specified non ancillary service


Summary:
Ensuring Quality in the Unemployment Insurance Program (EQUIP) Act - Amends title III (Grants to States for Unemployment Compensation Administration) of the Social Security Act (SSA) to require state unemployment compensation (UC) laws to require, as a condition of UC eligibility for a benefit year, an applicant, before receiving any UC, to: (1) complete a substance abuse risk assessment; and (2) test negative for controlled substances within one week after the results of such assessment if the state determines that the applicant is a high-risk. Prescribes retesting requirements and UC payment suspensions for applicants who test positive.

Amends SSA title XVIII (Medicare) and the Patient Protection and Affordable Care Act to provide funding for such substance abuse testing out of current funds appropriated for the Independent Payment Advisory Board (IPAB) and, after application of those funds, for the Consumer Operated and Oriented Plan (CO-OP) program.

ensuring quality unemployment insurance program equip act_-_amends title iii grants states unemployment compensation administration social_security_act ssa require state unemployment compensation laws require condition eligibility benefit year applicant receiving complete substance abuse risk assessment test negative controlled substances week results assessment state determines applicant high risk prescribes requirements payment suspensions applicants test positive amends ssa title xviii medicare patient_protection affordable care act provide funding substance abuse testing current funds appropriated independent_payment_advisory_board application funds consumer operated oriented plan program


Summary:
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2013 - Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of such Act to foster the establishment of state-administered controlled substance monitoring systems in order to ensure that appropriate law enforcement, regulatory, and state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists.

Amends the Public Health Service Act to revise and update the controlled substance monitoring program, including to: (1) allow grants to be used to maintain and operate existing state controlled substance monitoring programs, (2) require the Secretary of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, (3) require a state to provide the Secretary with aggregate data and other information to enable the Secretary to evaluate the success of the state's program and to submit a progress report to Congress, and (4) expand the program to include any commonwealth or territory of the United States.

Authorizes the Drug Enforcement Administration (DEA) or a state Medicaid program or state health department receiving nonidentifiable information from a controlled substance monitoring database to make such information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber use of the state's controlled substance monitoring system, and (2) educate prescribers on the benefits of the system both to them and society.

Revises preferences for grants related to drug abuse to authorize the Secretary to give preference to eligible states or tribes that put forth a good faith effort to meet minimum requirements under the controlled substance monitoring program.

national schedules prescription electronic reporting reauthorization act amends national schedules prescription electronic reporting act include purpose act foster establishment state administered controlled substance monitoring systems order ensure appropriate law enforcement regulatory state professional licensing authorities access prescription history information purposes investigating drug diversion prescribing dispensing practices prescribers pharmacists amends public_health_service_act revise update controlled substance monitoring program including allow grants maintain operate existing state controlled substance monitoring programs require secretary health_and_human_services hhs redistribute funds returned remaining grantees require state provide secretary aggregate data information enable secretary evaluate success state program submit progress report congress expand program include commonwealth territory united_states authorizes drug_enforcement_administration dea state medicaid program state health department receiving information controlled substance monitoring database information available entities research purposes requires state receiving grant facilitate prescriber use state controlled substance monitoring system educate prescribers benefits system society revises preferences grants related drug abuse authorize secretary preference eligible states tribes forth good faith effort meet minimum requirements controlled substance monitoring program


Summary:
Amends the Safe and Drug-Free Schools and Communities Act to require: (1) states to use grants for safe and drug-free schools to collect and report information on the incidence of bullying and harassment, and (2) local educational agencies (LEAs) and schools to use subgrants to prevent and respond to incidents of bullying and harassment.

Requires such LEAs or schools to: (1) notify parents and students annually of conduct prohibited in their school discipline policies, that now must include bullying and harassment; and (2) establish complaint procedures for students and parents to register complaints regarding such conduct.

Includes bullying and harassment within the Act's definition of violence.

amends safe drug free schools communities act require states use grants safe drug free schools collect report information incidence bullying harassment local educational agencies leas schools use subgrants prevent respond incidents bullying harassment requires leas schools notify parents students annually conduct prohibited school discipline policies include bullying harassment establish complaint procedures students parents register complaints conduct includes bullying harassment act definition violence


Summary:
Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale or offering for sale of a drug containing dextromethorphan, and not subject to practitioner supervision requirements, to an individual under age 18, except if the sale is made: (1) pursuant to a validly issued prescription; or (2) to an individual who provides proof of being actively enrolled in the military, including a valid military identification card. Imposes civil monetary penalties that escalate upon repeated violation.

Deems to be adulterated any unfinished dextromethorphan that is possessed, received, or distributed in violation of this Act. Prohibits a person from: (1) possessing or receiving unfinished dextromethorphan unless the person is registered with the Secretary of Health and Human Services (HHS) as a producer of a drug or device or otherwise registered, licensed, or approved under federal or state law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or (2) distributing unfinished dextromethorphan to any person other than a registered or otherwise authorized person. Excludes from such prohibitions common carriers that possess, receive, or distribute unfinished dextromethorphan for purposes of distributing it between registered, licensed, or approved persons. Imposes additional civil monetary penalties for such possession and distribution violations.

preventing abuse treatments act pact act_-_amends federal food drug cosmetic act prohibit sale offering sale drug containing dextromethorphan subject practitioner supervision requirements individual age sale pursuant validly issued prescription individual provides proof actively enrolled military including valid military identification card imposes civil monetary penalties repeated violation deems adulterated unfinished dextromethorphan possessed received distributed violation act prohibits person possessing receiving unfinished dextromethorphan person registered secretary health_and_human_services hhs producer drug device registered licensed approved federal state law engage practice pharmacy pharmaceutical production manufacture distribution drug ingredients distributing unfinished dextromethorphan person registered authorized person excludes prohibitions common carriers possess receive distribute unfinished dextromethorphan purposes distributing registered licensed approved persons imposes additional civil monetary penalties possession distribution violations


Summary:
Stop Overdose Stat Act or the S.O.S. Act - Requires the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) award grants or enter into cooperative agreements to enable eligible entities to reduce deaths occurring from drug overdoses, and (2) give priority to eligible public health agencies or community-based organizations that have expertise in preventing deaths occurring from overdoses in high risk populations.

Conditions receipt of a grant or agreement on an entity agreeing to: (1) use it for purchasing and distributing the drug naloxone, (2) report to the Secretary and the coordinating center (established under this Act) on the results of the activities supported, and (3) make available non-federal contributions of at least 50% of the federal funds provided. Requires a recipient to use such grant or agreement for: (1) educating prescribers and pharmacists about overdose prevention and naloxone prescription; (2) training first responders, other individuals in a position to respond to an overdose, and law enforcement and corrections officials on the effective response to individuals who have overdosed on drugs; (3) implementing and enhancing programs to provide overdose prevention, recognition, treatment, and response; and/or (4) expanding such activities.

Requires the Director to establish and provide for the operation of a coordinating center responsible for: (1) collecting, compiling, disseminating, and evaluating data on such activities; (2) developing best practices for preventing deaths occurring from drug overdoses; and (3) making such best practices specific to the type of community involved.

Requires the Director to award grants or cooperative agreements to improve drug overdose surveillance and reporting capabilities.

Amends the Public Health Service Act to require the Secretary to develop and submit to Congress a plan to reduce the number of deaths occurring from overdoses, to include implementation of a campaign to educate prescribers and the public about overdose prevention and naloxone prescription.

Requires the Director of the National Institute on Drug Abuse to: (1) prioritize and conduct or support research on drug overdose and overdose prevention, and (2) support research on the development of formulations of naloxone and dosage delivery devices specifically intended to be used for the prehospital treatment of unintentional drug overdose.

stop overdose act act_-_requires secretary health_and_human_services hhs acting director centers_for_disease_control_and_prevention cdc award grants enter cooperative agreements enable eligible entities reduce deaths occurring drug priority eligible public health agencies community based organizations expertise preventing deaths occurring high risk populations conditions receipt grant agreement entity agreeing use purchasing distributing drug naloxone report secretary coordinating center established act results activities supported available non federal contributions federal funds provided requires recipient use grant agreement educating prescribers pharmacists overdose prevention naloxone prescription training responders individuals position respond overdose law enforcement corrections officials effective response individuals drugs implementing enhancing programs provide overdose prevention recognition treatment response expanding activities requires director establish provide operation coordinating center responsible collecting compiling disseminating evaluating data activities developing best practices preventing deaths occurring drug making best practices specific type community involved requires director award grants cooperative agreements improve drug overdose surveillance reporting capabilities amends public_health_service_act require secretary develop submit congress plan reduce number deaths occurring include implementation campaign educate prescribers public overdose prevention naloxone prescription requires director national institute drug abuse prioritize conduct support research drug overdose overdose prevention support research development formulations naloxone dosage delivery devices specifically intended prehospital treatment unintentional drug overdose


Summary:
Opioid Overdose Reduction Act of 2014 - Exempts from liability for harm caused by the emergency administration of an opioid overdose drug:

 a health care professional who prescribes or provides such a drug to an individual at risk of experiencing an opioid overdose, or to another person in a position to assist such individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; a person who provides such a drug for emergency administration to an individual authorized to receive it as part of an opioid overdose program; and a person who provides for emergency administration of such a drug to an individual who reasonably appears to have suffered an overdose from heroin or another opioid if such person obtained such drug from a health care professional or as part of an opioid overdose program and was educated by such professional or program in the proper administration of such drug. Makes such exemptions inapplicable if the harm was caused by gross negligence or reckless misconduct.

opioid overdose reduction act exempts liability harm caused emergency administration opioid overdose drug health_care professional prescribes provides drug individual risk experiencing opioid overdose person position assist individual individual educated opioid overdose prevention treatment health_care professional government opioid overdose program person provides drug emergency administration individual authorized receive opioid overdose program person provides emergency administration drug individual reasonably appears suffered overdose heroin opioid person obtained drug health_care professional opioid overdose program educated professional program proper administration drug makes exemptions inapplicable harm caused gross negligence reckless misconduct


Summary: Expanding Opportunities for Recovery Act of 2014 - Requires the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states to expand access to clinically appropriate services for opioid abuse or addiction. Requires states to use these grants to provide up to 60 consecutive days of services to individuals who otherwise would not have access to substance abuse services.

expanding opportunities recovery_act requires administrator substance_abuse_and_mental_health_services_administration award grants states expand access clinically appropriate services opioid abuse addiction requires states use grants provide consecutive days services individuals access substance abuse services


Summary:
Opioid Abuse Prevention and Treatment Act of 2014 - Requires the Secretary of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive.

Amends the Public Health Service Act to require the Secretary to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. Requires the Administrator of the Health Resources and Services Administration to award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse.

Requires the Attorney General to request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug.

Directs the Food and Drug Administration (FDA) to consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription.

Requires the Secretary to use an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates.

Requires the Government Accountability Office (GAO) to review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.

opioid abuse prevention treatment act requires secretary health_and_human_services hhs award grants states develop peer_review process identify investigate inappropriate prescribing dispensing patterns drugs classified schedule iii controlled substances act drugs accepted medical use potential abused amends public_health_service_act require secretary establish grant programs facilitate training increase capacity health_care providers screen treat patients prevent drug abuse develop continuing education criteria allow health profession boards state agencies certify appropriate education safe prescribing schedule iii drugs requires administrator health_resources_and_services_administration award grants evaluate state health professions boards expanding authority providers prescribe drugs treat drug abuse requires attorney general request practitioners registered dispense controlled substances screen patients potential drug abuse prescribing schedule iii drug directs food_and_drug_administration fda consider naloxone prescription drug rapidly reverse overdose heroin opioids drugs effects similar opium available prescription requires secretary use interagency_working_group encourage states local governments increase opportunities disposal drugs derived opium reduce opportunities abuse requires government_accountability_office gao review federal opioid abuse activities recommendations reduce opioid abuse


Summary: Veterans Equal Access Act of 2014 - Directs the Secretary of Veterans Affairs (VA) to authorize VA health care providers to: (1) provide veterans with recommendations and opinions regarding participation in their state's marijuana programs, and (2) complete forms reflecting such recommendations and opinions.

veterans equal_access act directs secretary veterans_affairs authorize health_care providers provide veterans recommendations opinions participation state marijuana programs complete forms reflecting recommendations opinions


Summary:
Advancing FASD Research, Prevention, and Services Act - Amends the Public Health Service Act to revise and extend the Fetal Alcohol Spectrum Disorders (FASD) programs (as renamed under this Act, previously the Fetal Alcohol Syndrome and Fetal Alcohol Effect programs). Directs the Secretary of Health and Human Services (HHS) to: (1) establish and carry out a research agenda for FASD; (2) facilitate surveillance, public health research, and prevention of FASD; and (3) continue the Interagency Coordinating Committee on Fetal Alcohol Syndrome.

Requires the Secretary to provide financial assistance to: (1) establish or expand state FASD programs; (2) implement best practices to educate children with FASD, educate members of the criminal justice system on FASD, and educate adoption or foster care agency officials about services for children with FASD; (3) provide transitional services for those affected by prenatal alcohol exposure; (4) develop public service announcements to raise awareness of the risks associated with alcohol consumption during pregnancy; (5) increase awareness and identification of FASD in federally qualified health centers; and (6) provide respite care for caretakers, recruit mentors, and provide educational and supportive services to families of individuals with FASD.

Directs the Comptroller General (GAO) to make recommendations regarding the appropriate roles and responsibilities of federal entities with respect to programs and activities related to FASD.

Requires the Secretary of Education to direct the Office of Special Education and Rehabilitative Services to conduct training on FASD surveillance and disseminate best practices in the education and support of children with FASD.

Requires the Attorney General (DOJ) to direct the Office of Juvenile Justice and Delinquency Prevention to: (1) implement FASD screening procedures, (2) conduct training on surveillance and on identification and support of individuals with FASD, and (3) study the inadequacies of the current system.

advancing research prevention services act_-_amends public_health_service_act revise extend fetal alcohol spectrum disorders programs renamed act previously fetal alcohol syndrome fetal alcohol effect programs directs secretary health_and_human_services hhs establish carry research agenda facilitate surveillance public health research prevention continue interagency_coordinating_committee fetal alcohol syndrome requires secretary provide financial assistance establish expand state programs implement best practices educate children educate members criminal justice system educate adoption foster care agency officials services children provide transitional services affected prenatal alcohol exposure develop public service announcements raise awareness risks associated alcohol consumption pregnancy increase awareness identification federally qualified health centers provide respite care recruit mentors provide educational supportive services families individuals directs comptroller_general gao recommendations appropriate roles responsibilities federal entities respect programs activities related requires secretary education direct office special education rehabilitative services conduct training surveillance disseminate best practices education support children requires attorney general doj direct office_of_juvenile_justice delinquency_prevention implement screening procedures conduct training surveillance identification support individuals study current system


Summary:
Prescription Drug Abuse Prevention and Treatment Act of 2013 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse.

Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids, and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed.

Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse.

Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator.

Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report.

Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.

Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to require the development and application of specific prescription drug abuse prevention and treatment quality measures for each relevant health care provider setting.

prescription drug abuse prevention treatment act amends public_health_service_act direct administrator substance_abuse_and_mental_health_services_administration award grants states nonprofit entities consumer education opioid abuse including abuse amends controlled substances act set forth training requirements practitioners registered prescribe dispense opioids require registered opioid treatment clinic acceptable arrangements patient restricted having home dose controlled substance related treatment receive dose substance appropriate supervision clinic closed prohibits individual entity hospitals provide direct patient supervision prescribing dispensing prescription dispensation consistent current drug_enforcement_administration dea policy date controlled substances clinical standards commission publishes dosing guidelines finds safe clinically appropriate requires secretary health_and_human_services hhs establish commission develop publish guidelines related use including safe dosing guidelines forms benchmark guidelines reduction abuse requires states receiving controlled substances monitoring program grants provide information request drug enforcement officials relating individual subject active drug related investigation require opioid related deaths reported administrator directs administrator develop model opioid treatment program mortality report requires administrator establish implement national_center_for_health_statistics national opioid death registry track opioid related deaths requires secretary acting director agency healthcare_research_and_quality ahrq require development application specific prescription drug abuse prevention treatment quality measures relevant health_care provider setting


Summary:
Preventing Abuse of Cough Treatments Act of 2013 or PACT Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale or offering for sale of a drug containing dextromethorphan, and not subject to practitioner supervision requirements, to an individual under age 18, except if the sale is made: (1) pursuant to a validly issued prescription; or (2) to an individual who provides proof of being actively enrolled in the military, including a valid military identification card. Imposes civil monetary penalties that escalate upon repeated violation.

Deems to be adulterated any unfinished dextromethorphan that is possessed, received, or distributed in violation of this Act. Prohibits a person from: (1) possessing or receiving unfinished dextromethorphan unless the person is registered with the Secretary of Health and Human Services (HHS) as a producer of a drug or device or otherwise registered, licensed, or approved under federal or state law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or (2) distributing unfinished dextromethorphan to any person other than a registered or otherwise authorized person. Excludes from such prohibitions common carriers that possess, receive, or distribute unfinished dextromethorphan for purposes of distributing it between registered, licensed, or approved persons. Imposes additional civil monetary penalties for such possession and distribution violations.


Summary:
Combating Prescription Drug Abuse Act - Establishes the Combating Prescription Drug Abuse Commission, whose duties shall be to: (1) review and report to Congress on federal initiatives regarding efforts to prevent and reduce prescription drug abuse, (2) identify gaps and opportunities regarding the safe use of prescription drugs with the potential for diversion and abuse, and (3) make recommendations on specific ways to reduce diversion and abuse of prescription drugs.

Requires the report to describe Commission efforts to prevent or reduce drug diversion and abuse to ensure that patients continue to have access to medications and include specific recommendations for the Drug Enforcement Administration (DEA), the Food and Drug Administration (FDA), and other federal and state agencies concerning prescription drug monitoring and abuse.

combating prescription drug abuse act establishes combating prescription drug abuse commission duties shall review report congress federal initiatives efforts prevent reduce prescription drug abuse identify gaps opportunities safe use prescription drugs potential diversion abuse recommendations specific ways reduce diversion abuse prescription drugs requires report describe commission efforts prevent reduce drug diversion abuse ensure patients continue access medications include specific recommendations drug_enforcement_administration dea food_and_drug_administration fda federal state agencies concerning prescription drug monitoring abuse


Summary:
Increasing the Safety of Prescription Drug Use Act of 2013 - Amends the Public Health Service Act, with respect to state databases for controlled substance monitoring programs, to require the state to: (1) ensure that its database is interoperable with other such programs and electronic health records and provides updated patient information available to a practitioner; (2) require practitioners to use database information to help determine whether to prescribe or renew a prescription for a controlled substance; and (3) require dispensers, where permitted, to enter patient data required by the Secretary of Health and Human Services (HHS) into the database, including concerning methadone dispensed. Imposes confidentiality protections regarding patient information in the database.

Requires health care practitioners and dispensers who participate in or are employed by a federal or federally funded health care program, and federally qualified health centers, to use the databases of the controlled substance monitoring programs if they are available to the practitioner or dispenser.

Directs the Secretary to award grants to carry out a pilot project to develop a standardized peer review process and methodology to review and evaluate prescribing and pharmacy dispensing patterns.

Establishes a grant program to facilitate training to increase the capacity of health care providers to conduct patient screening and brief interventions. Requires health care providers who participate in or are employed by a federal health care program, and federally qualified health centers, to screen patients for abuse of prescription drugs or other controlled substances, conduct brief interventions, and provide referrals for known or suspected abuse of prescription drugs or other controlled substances. Requires the Secretary to award grants to states for: (1) evaluating the prospect of review by health professions boards of prescribing authorities of providers, and (2) development of continuing education criteria and review processes that allow health professions boards or state agencies to certify appropriate education and training for informed and safe prescribing of opioids and other drugs in schedules II and III of the Controlled Substances Act. Requires practitioners who register or renew a registration to dispense or conduct research with controlled substances in schedules II, III, IV, or V to certify that they have completed continuing medical education regarding prescription drug abuse (in the case of first-time registration) and regarding medical understanding of the proper use of all drugs listed in all of the controlled substances schedules (in the case of renewals). Directs the Attorney General to require a practitioner so registered to conduct patient screening for potential drug misuse or abuse before prescribing a schedule II or III drug, according to standards established by the state licensing body. Requires the Secretary to: (1) review naloxone to consider whether it should cease to be a prescription-only drug and be available as a behind-the-counter drug, in order to increase access of such drug to community-based organizations and street outreach organizations; and (2) convene or coordinate an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates and to reduce opportunities for abuse, as by establishing opioid dispensing limits at hospital emergency departments. Directs the Comptroller General (GAO) to review prescription drug abuse programs and policies in federal agencies and best practices with respect to prescription drug abuse programs of the states.

increasing safety prescription drug use act amends public_health_service_act respect state databases controlled substance monitoring programs require state ensure database interoperable programs electronic health records provides updated patient information available practitioner require practitioners use database information help determine prescribe renew prescription controlled substance require dispensers permitted enter patient data required secretary health_and_human_services hhs database including concerning dispensed imposes confidentiality protections patient information database requires health_care practitioners dispensers participate employed federal federally funded health_care program federally qualified health centers use databases controlled substance monitoring programs available practitioner dispenser directs secretary award grants carry pilot project develop standardized peer_review process methodology review evaluate prescribing pharmacy dispensing patterns establishes grant program facilitate training increase capacity health_care providers conduct patient screening brief interventions requires health_care providers participate employed federal health_care program federally qualified health centers screen patients abuse prescription drugs controlled substances conduct brief interventions provide referrals known suspected abuse prescription drugs controlled substances requires secretary award grants states evaluating review health professions boards prescribing authorities providers development continuing education criteria review processes allow health professions boards state agencies certify appropriate education training informed safe prescribing opioids drugs schedules iii controlled substances act requires practitioners register renew registration dispense conduct research controlled substances schedules iii certify completed continuing medical education prescription drug abuse case time registration medical understanding proper use drugs listed controlled substances schedules case renewals directs attorney general require practitioner registered conduct patient screening potential drug misuse abuse prescribing schedule iii drug according standards established state licensing body requires secretary review naloxone consider cease prescription drug available counter drug order increase access drug community based organizations street outreach organizations convene coordinate interagency_working_group encourage states local governments increase opportunities disposal reduce opportunities abuse establishing opioid dispensing limits hospital emergency departments directs comptroller_general gao review prescription drug abuse programs policies federal agencies best practices respect prescription drug abuse programs states


Summary:
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014 - Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of such Act to foster the establishment of state-administered controlled substance monitoring systems in order to ensure that appropriate law enforcement, regulatory, and state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists.

 Amends the Public Health Service Act to revise and update the controlled substance monitoring program, including to:

 allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require submission by a state of a plan to apply the latest advances in health information technology to incorporate prescription drug monitoring program data directly into the workflow of prescribers and dispensers, require timelines and descriptions for implementation of interoperability for purposes of information sharing with a bordering state that already operates a monitoring program, require health information interoperability standards to be consistent with at least one health information technology system, require the Secretary of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide the Secretary with aggregate data and other information to enable the Secretary to evaluate the success of the state's program and to submit a progress report to Congress, and expand the program to include any commonwealth or territory of the United States. Authorizes the Drug Enforcement Administration (DEA) or a state Medicaid program or health department receiving nonidentifiable information from a controlled substance monitoring database to make such information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

 Removes the preferences for grants related to drug abuse for states with approved applications to implement controlled substances monitoring programs.

Revises requirements for studies on progress to include assessment of the effects upon linkages to substance abuse disorder services and interoperability with health information technology systems.

national schedules prescription electronic reporting reauthorization act amends national schedules prescription electronic reporting act include purpose act foster establishment state administered controlled substance monitoring systems order ensure appropriate law enforcement regulatory state professional licensing authorities access prescription history information purposes investigating drug diversion prescribing dispensing practices prescribers pharmacists amends public_health_service_act revise update controlled substance monitoring program including allow grants maintain operate existing state controlled substance monitoring programs require submission state plan apply latest advances health information technology incorporate prescription drug monitoring program data directly prescribers dispensers require timelines descriptions implementation interoperability purposes information sharing bordering state operates monitoring program require health information interoperability standards consistent health information technology system require secretary health_and_human_services hhs redistribute funds returned remaining grantees require state provide secretary aggregate data information enable secretary evaluate success state program submit progress report congress expand program include commonwealth territory united_states authorizes drug_enforcement_administration dea state medicaid program health department receiving information controlled substance monitoring database information available entities research purposes requires state receiving grant facilitate prescriber dispenser use state controlled substance monitoring system educate prescribers dispensers benefits system society removes preferences grants related drug abuse states approved applications implement controlled substances monitoring programs revises requirements studies progress include assessment effects linkages substance abuse disorder services interoperability health information technology systems


Summary:
Overdose Prevention Act - Amends the Public Health Service Act to require the Director of the Centers for Disease Control and Prevention (CDC) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other opioids, which are drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response. Requires the CDC to improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

Directs the Secretary of Health and Human Services (HHS) to establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

Requires the Director of the National Institute on Drug Abuse (NIDA) to prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. Directs NIDA to support research on drug overdose treatments that can be administered by lay persons or first responders.

overdose prevention act_-_amends public_health_service_act require director centers_for_disease_control_and_prevention cdc enter cooperative agreements reduce deaths drug purchasing distributing naloxone medication rapidly reverses overdose heroin opioids drugs effects similar opium similar drug educating training public responders health professionals drug overdose prevention response requires cdc improve drug overdose surveillance entering cooperative agreements provide training improve identification drug overdose cause death establish national program reporting drug directs secretary health_and_human_services hhs establish coordinating center develop plan reduce drug overdose deaths educating public overdose prevention recommending improvements overdose prevention programs requires director national institute drug abuse prioritize conduct support research circumstances contribute drug overdose drugs associated fatal overdose overdose prevention methods directs support research drug overdose treatments administered lay persons responders


Summary:
Sober Truth on Preventing Underage Drinking Reauthorization Act or STOP Act - Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2015-FY2018.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Secretary of Health and Human Services (HHS) to collect data and conduct or support new research on underage drinking that improves and conducts public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.

Amends the Federal Alcohol Administration Act to prohibit the manufacture, sale, distribution, or possession of powdered alcohol.

truth preventing drinking reauthorization act stop act_-_amends public_health_service_act reauthorize program reduce drinking fy2015 fy2018 revises reporting requirements state programs drinking specifies additional requirements development national media campaign prevent drinking directs administrator substance_abuse_and_mental_health_services_administration grants professional pediatric provider organizations increase effective practices including screening children adolescents alcohol use reduce prevalence alcohol use individuals age including college students directs secretary health_and_human_services hhs collect data conduct support new research drinking improves conducts public health surveillance alcohol use alcohol related conditions states individuals age increasing use surveys behavioral risk factor surveillance system monitor excessive drinking related harms amends federal alcohol administration act prohibit manufacture sale distribution possession alcohol


Summary:
Veterans Equal Access Act

Directs the Secretary of Veterans Affairs (VA) to authorize VA health care providers to: (1) provide veterans with recommendations and opinions regarding participation in their state's marijuana programs, and (2) complete forms reflecting such recommendations and opinions.


Summary:
Sober Truth on Preventing Underage Drinking Reauthorization Act or the STOP Act

Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2016-FY2020.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Department of Health and Human Services to collect data and conduct or support new research on underage drinking that carries out and improves public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.

truth preventing drinking reauthorization act stop act amends public_health_service_act reauthorize program reduce drinking fy2016-fy2020 revises reporting requirements state programs drinking specifies additional requirements development national media campaign prevent drinking directs substance_abuse_and_mental_health_services_administration grants professional pediatric provider organizations increase effective practices including screening children adolescents alcohol use reduce prevalence alcohol use individuals age including college students directs_the_department_of_health_and_human_services collect data conduct support new research drinking carries improves public health surveillance alcohol use alcohol related conditions states individuals age increasing use surveys behavioral risk factor surveillance system monitor excessive drinking related harms


Summary:
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

 (Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

 allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and expand the program to include any commonwealth or territory of the United States. Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

national schedules prescription electronic reporting reauthorization act sec amends national schedules prescription electronic reporting act include purpose state administered controlled substance monitoring systems ensuring access prescription history information investigative purposes appropriate law enforcement regulatory state professional licensing authorities sec amends public_health_service_act revise reauthorize fy2020 controlled substance monitoring program including allow grants maintain operate existing state controlled substance monitoring programs require department_of_health_and_human_services hhs redistribute funds returned remaining grantees require state provide hhs aggregate data information enable hhs evaluate success state program expand program include commonwealth territory united_states allows drug_enforcement_administration hhs state medicaid program state health department state substance abuse agency receiving information controlled substance monitoring database research purposes information available entities research purposes requires state receiving grant facilitate prescriber dispenser use state controlled substance monitoring system educate prescribers dispensers benefits system society


Summary:
Opioid Overdose Reduction Act of 2015

This bill exempts individuals from liability for harm caused by the emergency administration of an opioid overdose drug under certain circumstances. (An opioid is a drug with effects similar to opium, such as heroin.) The individuals exempted from liability are:

 a health care professional who prescribes or provides an opioid overdose drug to an individual at risk of experiencing an opioid overdose or to another individual in a position to assist the individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; an individual who provides an opioid overdose drug for emergency administration to another individual authorized to receive it as part of an opioid overdose program; and an individual who administers an opioid overdose drug to another individual who appears to have suffered an opioid overdose if the individual obtained the drug from a health care professional or as part of an opioid overdose program and was educated by the professional or program in the proper administration of the drug. These exemptions are inapplicable if the harm was caused by gross negligence or reckless misconduct.

States can preempt these exemptions by providing additional protections from liability for individuals that administer opioid overdose drugs, or by enacting legislation making the Act not applicable to state civil action involving only citizens from that state.

opioid overdose reduction act bill exempts individuals liability harm caused emergency administration opioid overdose drug certain circumstances opioid drug effects similar opium heroin individuals exempted liability health_care professional prescribes provides opioid overdose drug individual risk experiencing opioid overdose individual position assist individual individual educated opioid overdose prevention treatment health_care professional government opioid overdose program individual provides opioid overdose drug emergency administration individual authorized receive opioid overdose program individual administers opioid overdose drug individual appears suffered opioid overdose individual obtained drug health_care professional opioid overdose program educated professional program proper administration drug exemptions inapplicable harm caused gross negligence reckless misconduct states preempt exemptions providing additional protections liability individuals administer opioid overdose drugs enacting legislation making act applicable state civil action involving citizens state


Summary:
Breaking Addiction Act of 2015

This bill directs the Secretary of Health and Human Services to provide for waiver of the limitation on medical assistance to certain patients in an institution for mental diseases (IMD limitation) in order to permit medical assistance under title XIX (Medicaid) of the Social Security Act for the treatment of a substance use condition for a qualified individual in a community-based institution for mental diseases.

breaking addiction act bill directs secretary health_and_human_services provide waiver limitation medical assistance certain patients institution mental diseases limitation order permit medical assistance title xix medicaid social_security_act treatment substance use condition qualified individual community based institution mental diseases


Summary:
Medicare Patient Safety and Drug Abuse Prevention Act

Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to authorize a prescription drug plan (PDP) sponsor to establish a drug management program for at-risk beneficiaries.

Requires a PDP sponsor, with respect to covered part D drugs, to have in place, directly or through appropriate arrangements, a utilization management tool designed to prevent: (1) the abuse of frequently abused drugs by individuals, and (2) the diversion of such drugs at pharmacies.

Directs the Department of Health and Human Services (HHS) to authorize Medicare drug integrity contractors (MEDICs) to accept directly an individual's prescription and necessary medical records from pharmacies, PDPs, and physicians in order for MEDICs to provide information relevant to determining whether the individual is an at-risk beneficiary.

Requires the Inspector General of HHS to study the effectiveness of MEDICs in identifying, combating, and preventing fraud under the Medicare program.

Expresses the sense of Congress that Medicare Advantage organizations and PDP sponsors should consider using e-prescribing and other health information technology tools to support combating fraud under MA-PD plans and prescription drug plans under parts C (Medicare+Choice) and D.

medicare patient safety drug abuse prevention act amends voluntary prescription drug benefit program title xviii medicare social_security_act authorize prescription drug plan pdp sponsor establish drug management program risk beneficiaries requires pdp sponsor respect covered drugs place directly appropriate arrangements utilization management tool designed prevent abuse frequently abused drugs individuals diversion drugs pharmacies directs_the_department_of_health_and_human_services hhs authorize medicare drug integrity contractors medics accept directly individual prescription necessary medical records pharmacies pdps physicians order medics provide information relevant determining individual risk beneficiary requires inspector_general hhs study effectiveness medics identifying combating preventing fraud medicare program expresses sense congress medicare_advantage organizations pdp sponsors consider prescribing health information technology tools support combating fraud ma-pd plans prescription drug plans parts


Summary:
Dispose Responsibly of your Pills Act of 2015 or the DROP Act of 2015

Authorizes the Attorney General, in coordination with the Administrator of the Drug Enforcement Administration (DEA), the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, to make grants to eligible entities to expand or make available disposal sites for unwanted prescription medications.

Defines "eligible entity" to include:

 a state, local, or tribal law enforcement agency; a manufacturer, distributor, or reverse distributor of prescription medications; a retail pharmacy; a registered narcotic treatment program; a hospital or clinic with an on-site pharmacy; and an eligible long-term care facility. Requires a recipient to use a grant for:

 expenses of a prescription drug disposal site; implementing disposal procedures and processes and community education strategies; replicating a prescription drug take back initiative throughout multiple jurisdictions; and training of law enforcement officers and other community participants. Limits grants to not more than $250,000 for not longer than two years.

Directs the Attorney General to make a grant: (1) to provide technical assistance and training for a grant recipient, and (2) for evaluation of each recipient's performance. Requires recipients to report each fiscal year on: (1) the effectiveness of their prescription drug take back programs, and (2) the effect of disposal efforts on drug circulation.

dispose responsibly act drop act authorizes attorney general coordination administrator drug_enforcement_administration dea secretary health_and_human_services director office_of_national_drug_control_policy grants eligible entities expand available disposal sites unwanted prescription medications defines eligible entity include state local tribal law enforcement agency manufacturer distributor reverse distributor prescription medications retail pharmacy registered narcotic treatment program hospital clinic site pharmacy eligible long-term_care facility requires recipient use grant expenses prescription drug disposal site implementing disposal procedures processes community education strategies replicating prescription drug initiative multiple jurisdictions training law enforcement officers community participants limits grants longer years directs attorney general grant provide technical assistance training grant recipient evaluation recipient performance requires recipients report fiscal year effectiveness prescription drug programs effect disposal efforts drug circulation


Summary:
Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015

This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.

This bill amends the Public Health Service Act to revise and extend through FY2020 the controlled substance monitoring program.

Government entities receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020.

HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium).

The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the DEA, must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids.

The DEA, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone).

heroin prescription opioid abuse prevention education enforcement act bill requires department_of_health_and_human_services hhs cooperation department_of_veterans_affairs department_of_defense drug_enforcement_administration dea convene pain management best practices inter agency task_force develop study best practices pain management prescription pain medication bill amends public_health_service_act revise extend fy2020 controlled substance monitoring program government entities receiving information controlled substance monitoring database research purposes information available entities research purposes state receiving grant controlled substance monitoring program facilitate prescriber dispenser use state controlled substance monitoring system educate prescribers dispensers benefits system bill amends omnibus_crime_control_and_safe_streets_act extend edward_byrne_memorial_justice assistance grant program fy2020 hhs advance education awareness risk abuse prescription opioids drugs effects similar opium office_of_national_drug_control_policy coordination hhs dea establish national drug awareness campaign emphasizes similarities heroin prescription opioids dea coordination hhs grants state local tribal governments create demonstration programs allow responders prevent opioid overdose death administering opioid overdose reversal drug naloxone


Summary:
Stop Overdose Stat Act of 2015

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response.

SAMHSA must establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

The Centers for Disease Control and Prevention must improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

The National Institute on Drug Abuse (NIDA) must prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. NIDA must support research on drug overdose treatments that can be administered by lay persons or first responders.

stop overdose act bill amends public_health_service_act require substance_abuse_and_mental_health_services_administration samhsa enter cooperative agreements reduce deaths drug purchasing distributing naloxone medication rapidly reverses overdose heroin drugs effects similar opium similar drug educating training public responders health professionals drug overdose prevention response samhsa establish coordinating center develop plan reduce drug overdose deaths educating public overdose prevention recommending improvements overdose prevention programs centers_for_disease_control_and_prevention improve drug overdose surveillance entering cooperative agreements provide training improve identification drug overdose cause death establish national program reporting drug national institute drug abuse prioritize conduct support research circumstances contribute drug overdose drugs associated fatal overdose overdose prevention methods support research drug overdose treatments administered lay persons responders


Summary:
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

DXM Abuse Prevention Act of 2015

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.

(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

measure amended introduced summary expanded action occurred measure abuse prevention act sec bill amends federal food drug cosmetic act prohibit sale drug containing dextromethorphan drug abuse individual age individual prescription actively enrolled military retailers selling implement verification system ensure compliance civil monetary penalties repeated violation imposed sec unfinished possessed distributed received persons registered food_and_drug_administration producers drug medical device allowed engage practice pharmacy pharmaceutical production manufacture distribution drug ingredients common carriers distributing unfinished authorized persons exempted civil monetary penalties imposed possession distribution violations


Summary:
Expanding Opportunities for Recovery Act of 2015

This bill requires the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration to award grants to states to expand access to clinically appropriate services for opioid abuse or addiction. States must use these grants to provide up to 60 consecutive days of services to individuals who otherwise would not have access to substance abuse services.

expanding opportunities recovery_act bill requires center_for_substance_abuse_treatment substance_abuse_and_mental_health_services_administration award grants states expand access clinically appropriate services opioid abuse addiction states use grants provide consecutive days services individuals access substance abuse services


Summary:
Opioid Abuse Prevention and Treatment Act of 2015

This bill requires the Department of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive.

This bill amends the Public Health Service Act to require HHS to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. The Health Resources and Services Administration must award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse.

The Drug Enforcement Administration must request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug.

The Food and Drug Administration must consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription.

HHS must convene or coordinate with an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates.

The Government Accountability Office must review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.

opioid abuse prevention treatment act bill requires department_of_health_and_human_services hhs award grants states develop peer_review process identify investigate inappropriate prescribing dispensing patterns drugs classified schedule iii controlled substances act drugs accepted medical use potential abused bill amends public_health_service_act require hhs establish grant programs facilitate training increase capacity health_care providers screen treat patients prevent drug abuse develop continuing education criteria allow health profession boards state agencies certify appropriate education safe prescribing schedule iii drugs health_resources_and_services_administration award grants evaluate state health professions boards expanding authority providers prescribe drugs treat drug abuse drug_enforcement_administration request practitioners registered dispense controlled substances screen patients potential drug abuse prescribing schedule iii drug food_and_drug_administration consider naloxone prescription drug rapidly reverse overdose heroin opioids drugs effects similar opium available prescription hhs convene coordinate interagency_working_group encourage states local governments increase opportunities disposal drugs derived opium reduce opportunities abuse government_accountability_office review federal opioid abuse activities recommendations reduce opioid abuse


Summary:
Co-Prescribing to Reduce Overdoses Act of 2016

(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.

(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.

(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.

prescribing reduce act sec bill permits department_of_health_and_human_services hhs establish grant program support prescribing opioid overdose reversal drugs naloxone patients elevated risk overdose including patients prescribed opioid opioids drugs effects similar opium heroin certain pain medications grant recipients use funds purchase opioid overdose reversal drugs establish program prescribing drugs train health_care providers pharmacists track patients outcomes offset patient cost sharing conduct community outreach connect patients treatment sec hhs provide information prescribers federally qualified health centers indian_health_service facilities best practices prescribing opioid overdose reversal drugs patients elevated risk overdose sec bill amends public_health_service_act reduce offset authorization appropriations centers_for_disease_control_and_prevention facilities fy2018


Summary:
Safer Prescribing of Controlled Substances Act

This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration, as a condition of granting or renewing the registration of a covered practitioner to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, to require such practitioner to complete training that the Department of Health and Human Services (HHS) determines meets the requirements of this bill. It defines a "covered practitioner" as a practitioner that is not a hospital, pharmacy, or veterinarian.

It requires such training to expose covered practitioners to:

 best practices for pain management, including alternatives to prescribing controlled substances; responsible prescribing of pain medications; methods for diagnosing, treating, and managing a substance use disorder, including evidence-based nonpharmacological therapies; ways of linking patients to evidence-based treatment for substance use disorders; and tools to manage adherence and diversion of controlled substances. The Substance Abuse and Mental Health Services Administration must establish or support the establishment of at least one free, online training module that meets such requirements to be provided to any covered practitioner registered or applying for registration.

The bill requires HHS: (1) to establish, maintain, and periodically update a publicly available database providing information on such training modules; and (2) within five years after enactment of this bill, to evaluate and make publicly available a report describing how exposure to training required by this bill has changed prescribing patterns of controlled substances.

safer prescribing controlled substances act bill amends controlled substances act direct drug_enforcement_administration condition granting renewing registration covered practitioner dispense conduct research controlled substances schedule iii require practitioner complete training department_of_health_and_human_services hhs determines meets requirements bill defines covered practitioner practitioner hospital pharmacy veterinarian requires training expose covered practitioners best practices pain management including alternatives prescribing controlled substances responsible prescribing pain medications methods diagnosing treating managing substance use disorder including evidence based therapies ways linking patients evidence based treatment substance use disorders tools manage adherence diversion controlled substances substance_abuse_and_mental_health_services_administration establish support establishment free online training module meets requirements provided covered practitioner registered applying registration bill requires hhs establish maintain periodically update publicly available database providing information training modules years enactment bill evaluate publicly available report describing exposure training required bill changed prescribing patterns controlled substances


Summary:
The Reforming and Expanding Access to Treatment Act or the TREAT Act

This bill amends title XIX (Medicaid) of the Social Security Act to allow federal payment for qualified substance use disorder services furnished to inmates in public institutions under state Medicaid programs. "Qualified substance use disorder services" include medication or behavioral treatment administered to eliminate, mitigate, treat, or cure an individual's substance abuse disorder or use or abuse of drugs.

The Substance Abuse and Mental Health Services Administration shall not establish, maintain, or implement any policy that restricts its statutorily authorized provision or support of substance abuse treatment for incarcerated individuals.

reforming expanding access treatment act treat act bill amends title xix medicaid social_security_act allow federal payment qualified substance use disorder services furnished inmates public institutions state medicaid programs qualified substance use disorder services include medication behavioral treatment administered eliminate mitigate treat cure individual substance abuse disorder use abuse drugs substance_abuse_and_mental_health_services_administration shall establish maintain implement policy restricts statutorily authorized provision support substance abuse treatment incarcerated individuals


Summary:
Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015

This bill amends the Controlled Substances Act to include in the definition of a "controlled substance analogue" a substance designated as such by the Controlled Substance Analogue Committee (established by this bill).

It directs the Drug Enforcement Administration (DEA) to establish such Committee as an interagency committee headed by the DEA and comprised of scientific experts in the fields of chemistry and pharmacology from the DEA, the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and any other federal agency determined by the DEA to be appropriate.

 The Committee may designate, and shall establish and maintain a list of, controlled substance analogues determined to be similar to a schedule I or II controlled substance in either chemical structure or predictive effect on the body in such a manner as to make it likely that the substance will, or can be reasonably expected to, have a potential for abuse. The DEA must publish a description of each designation made by the Committee.

The bill amends the Controlled Substances Import and Export Act to prohibit the importation of any controlled substance analogue except pursuant to such notification or declaration as the DEA may prescribe.

It directs the U.S. Sentencing Commission to review and, if appropriate, amend the federal sentencing guidelines and policy statements to ensure that they provide adequate penalties for any offense involving the unlawful manufacturing, importing, exporting, or trafficking of controlled substance analogues and similar offenses.

protecting youth dangerous synthetic drugs act bill amends controlled substances act include definition controlled substance analogue substance designated controlled substance analogue committee established bill directs drug_enforcement_administration dea establish committee interagency_committee headed dea comprised scientific experts fields chemistry pharmacology dea national institute drug abuse centers_for_disease_control_and_prevention federal agency determined dea appropriate committee designate shall establish maintain list controlled substance determined similar schedule controlled substance chemical structure predictive effect body manner likely substance reasonably expected potential abuse dea publish description designation committee bill amends controlled_substances_import_and_export_act prohibit importation controlled substance analogue pursuant notification declaration dea prescribe directs sentencing commission review appropriate amend federal sentencing guidelines policy statements ensure provide adequate penalties offense involving unlawful manufacturing importing exporting trafficking controlled substance similar offenses


Summary: This bill requires the Department of Veterans Affairs (which currently is simply authorized) to disclose information about a veteran or dependent to a state controlled substance monitoring program to the extent necessary to prevent misuse and diversion of prescription medicines.

bill requires department_of_veterans_affairs currently simply authorized disclose information veteran dependent state controlled substance monitoring program extent necessary prevent misuse diversion prescription medicines


Summary:
Access to Substance Abuse Treatment Act of 2016

This bill amends the Public Health Service Act to allow the Substance Abuse and Mental Health Services Administration (SAMHSA) to make grants to: (1) increase the availability of treatment for abuse of opioids (drugs with effects similar to opium, such as heroin), cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP); (2) provide vouchers to individuals in underserved populations for services related to such treatment; and (3) establish programs to provide for and coordinate the provision of services, including medical services, job training services, and housing assistance, to individuals reentering the community after successfully receiving treatment for abuse of such substances.

The grant program to provide residential substance abuse treatment to pregnant and postpartum women is revised to: (1) make caregiver parents eligible for treatment, (2) make Indian tribes and tribal organizations eligible for grants, and (3) set forth the priority for allocation of grants.

The National Institute on Drug Abuse must conduct research on the effectiveness of drugs to reduce the problems associated with stimulant abuse.

The Department of Health and Human Services must seek to enter into a contract with the National Academy of Medicine (formerly known as the Institute of Medicine) to complete a literature review on the effectiveness of drugs for the treatment of stimulant abuse.

The Government Accountability Office must study: (1) the impact of the programs authorized by this Act, (2) how the level of federal funding available for such treatment compares to the amount necessary to provide adequate treatment, and (3) the cost savings of effective treatment due to the reduced need for criminal justice and other services.

access substance abuse treatment act bill amends public_health_service_act allow substance_abuse_and_mental_health_services_administration samhsa grants increase availability treatment abuse opioids drugs effects similar opium heroin cocaine methamphetamine provide vouchers individuals underserved populations services related treatment establish programs provide coordinate provision services including medical services job training services housing assistance individuals reentering community successfully receiving treatment abuse substances grant program provide residential substance abuse treatment pregnant postpartum women revised caregiver parents eligible treatment indian tribes tribal organizations eligible grants set forth priority allocation grants national institute drug abuse conduct research effectiveness drugs reduce problems associated abuse department_of_health_and_human_services seek enter contract national academy medicine known institute_of_medicine complete literature review effectiveness drugs treatment abuse government_accountability_office study impact programs authorized act level federal funding available treatment compares necessary provide adequate treatment cost savings effective treatment reduced need criminal justice services


Summary:
Heroin and Prescription Drug Abuse Prevention and Reduction Act

This bill amends the Controlled Substances Act to revise requirements for and limitations on practitioners who dispense narcotic drugs for maintenance or detoxification treatment.

The Department of Health and Human Services (HHS) must establish grant programs to: (1) encourage prescribing and purchase of opioid overdose reversal drugs (e.g., naloxone), and (2) develop prescribing guidelines for such drugs. (Opioids are drugs with effects similar to opium, such as heroin or certain pain medications.)

The Centers for Disease Control and Prevention must provide support to improve drug overdose surveillance and reporting capabilities.

HHS may support syringe exchange programs.

The Substance Abuse and Mental Health Services Administration must provide support to: (1) reduce drug overdose deaths; and (2) develop, expand, and enhance substance use recovery support services.

This bill amends the Public Health Service Act to extend residential treatment programs for pregnant and postpartum women.

The Center for Substance Abuse Treatment must: (1) carry out a pilot program to support services for pregnant and postpartum women with a substance use disorder; (2) award grants to expand treatment activities in areas with a high rate of, or a rapid increase in, the use of opioids; and (3) support increasing the capacity of substance use disorder services for adolescents.

This bill amends the Employee Retirement Income Security Act of 1974 (ERISA) and Internal Revenue Code to direct HHS and the Departments of Labor and the Treasury to require disclosures, issue guidance, conduct audits, and publish information regarding the requirement for group health plans and health insurance coverage to have parity between mental health and substance use disorder benefits and medical and surgical benefits. HHS must establish a consumer parity portal website.

HHS must establish a loan repayment program for substance use disorder health professionals.

heroin prescription drug abuse prevention reduction act bill amends controlled substances act revise requirements limitations practitioners dispense narcotic drugs maintenance detoxification treatment department_of_health_and_human_services hhs establish grant programs encourage prescribing purchase opioid overdose reversal drugs naloxone develop prescribing guidelines drugs opioids drugs effects similar opium heroin certain pain medications centers_for_disease_control_and_prevention provide support improve drug overdose surveillance reporting capabilities hhs support exchange programs substance_abuse_and_mental_health_services_administration provide support reduce drug overdose deaths develop expand enhance substance use recovery support services bill amends public_health_service_act extend residential treatment programs pregnant postpartum women center_for_substance_abuse_treatment carry pilot program support services pregnant postpartum women substance use disorder award grants expand treatment activities areas high rate rapid increase use opioids support increasing capacity substance use disorder services adolescents bill amends employee retirement income security act erisa internal_revenue_code direct hhs departments_of_labor treasury require disclosures issue guidance conduct audits publish information requirement group health plans health insurance coverage parity mental health substance use disorder benefits medical surgical benefits hhs establish consumer parity portal website hhs establish loan repayment program substance use disorder health professionals


Summary:
Servicemembers and Veterans Prescription Drug Safety Act of 2016

 This bill directs the Department of Defense (DOD) and the Department of Justice (DOJ) to carry out a joint program under which an eligible person who has lawfully obtained a covered controlled substance may deliver it for disposal at a facility to be specified by DOD and DOJ.

An eligible person for this purpose shall be:

 a member of the Armed Forces, an individual receiving or entitled to military retired or retainer pay, a member's dependent-beneficiary who is receiving certain health care services, or any person lawfully entitled to dispose of the property of any of such individuals who dies in lawful possession of a controlled substance for personal use. DOD and DOJ shall develop guidelines and procedures to prevent the diversion, misuse, theft, or loss of such substances delivered under the program.

DOJ and the Department of Veterans Affairs (VA) shall carry out a similar joint program covering any veteran, veteran's spouse or dependent, a person in receipt of medical services at a VA facility, or any person lawfully entitled to dispose of the property of any of such individuals who dies in lawful possession of a controlled substance for personal use.

DOJ and the VA shall also develop guidelines and procedures to prevent the diversion, misuse, theft, or loss of such substances delivered under the program.

servicemembers veterans prescription drug safety act bill directs department_of_defense dod department_of_justice doj carry joint program eligible person lawfully obtained covered controlled substance deliver disposal facility specified dod doj eligible person purpose shall member armed_forces individual receiving entitled military retired retainer pay member dependent beneficiary receiving certain health_care services person lawfully entitled dispose property individuals dies lawful possession controlled substance personal use dod doj shall develop guidelines procedures prevent diversion misuse theft loss substances delivered program doj department_of_veterans_affairs shall carry similar joint program covering veteran veteran spouse dependent person receipt medical services facility person lawfully entitled dispose property individuals dies lawful possession controlled substance personal use doj shall develop guidelines procedures prevent diversion misuse theft loss substances delivered program


Summary:
Prevent Drug Addiction Act of 2016

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants for consumer education about opioid addiction. (Opioids are drugs with effects similar to opium, such as heroin or certain prescription painkillers.)

This bill amends the Controlled Substances Act to require medical practitioners to be trained in the treatment of opioid-dependent patients, pain management, and early detection of opioid addiction before they can be registered by the Drug Enforcement Administration to dispense opioids.

Opioid treatment programs that close on any day must make arrangements for each patient to receive treatment during the closure, as necessary.

A report must be submitted to SAMHSA for each individual who dies while receiving treatment in an opioid treatment program. In states receiving funding for controlled substance monitoring programs, deaths where an opioid drug is detected in the body must be reported to SAMHSA.

The National Center for Health Statistics of the Centers for Disease Control and Prevention must establish a National Opioid Death Registry to track opioid-related deaths.

The Agency for Healthcare Research and Quality must develop and apply prescription drug addiction prevention and treatment quality measures.

This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to allow prescription drug plan (PDP) sponsors to limit the access of certain beneficiaries to addictive drugs. PDP sponsors must have a utilization management tool to prevent drug addiction.

Medicare Drug Integrity Contractors may accept prescription and medical records to determine whether a beneficiary is at risk for prescription drug addiction.

prevent drug addiction act bill amends public_health_service_act require substance_abuse_and_mental_health_services_administration samhsa award grants consumer education opioid addiction opioids drugs effects similar opium heroin certain prescription bill amends controlled substances act require medical practitioners trained treatment opioid dependent patients pain management early detection opioid addiction registered drug_enforcement_administration dispense opioids opioid treatment programs close day arrangements patient receive treatment closure necessary report submitted samhsa individual dies receiving treatment opioid treatment program states receiving funding controlled substance monitoring programs deaths opioid drug detected body reported samhsa national_center_for_health_statistics centers_for_disease_control_and_prevention establish national opioid death registry track opioid related deaths agency healthcare_research_and_quality develop apply prescription drug addiction prevention treatment quality measures bill amends voluntary prescription drug benefit program title xviii medicare social_security_act allow prescription drug plan pdp sponsors limit access certain beneficiaries drugs pdp sponsors utilization management tool prevent drug addiction medicare drug integrity contractors accept prescription medical records determine beneficiary risk prescription drug addiction